Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis 孤発性筋萎縮性側索硬化症(ALS)患者における糞便微生物叢移植の効果 無作為化二重盲検プラセボ対照試験 https://t.co/lt2SjRIWQQ https://t.co/JrtdVs3C6l
Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2024All 7 dated mentions so far are from Dec 2024.
Where it's discussed
-
X / Twitter5 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions demonstrate strong interest in the role of the gut microbiome in ALS, with several posters highlighting the pioneering nature of fecal microbiota transplantation, such as 'potential role in ALS' and 'effects on sporadic ALS patients.' Words like 'highlight,' 'potential,' and 'study's contribution' reflect curiosity and acknowledgment of the research's significance, though some comments remain cautious about immediate clinical applications.
Most discussions recognize the study's contribution to understanding the gut's role in ALS and seem to agree with its significance.
Many posts show high curiosity, especially with mentions of the potential for microbiome-based therapies and the innovative nature of fecal transplantation.
Some commenters delve into the methodology and implications, indicating active engagement, though others express curiosity than deep critique.
The collective sentiment suggests the study could influence future research, as discussions highlight its potential to open new treatment avenues.
Top posts
Most liked on X and BlueskyNew trial highlights the gut #microbiome 's potential role in #ALS, specifically examining the effects of fecal #microbiota transplantation on sporadic ALS patients. https://t.co/8WrcAYO8OD https://t.co/gRmOEmvLrW
Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial - PubMed https://t.co/c1wNoMsdHw
散発性筋萎縮性側索硬化症患者に対する糞便微生物移植の効果:ランダム化二重盲検プラセボ対照試験 https://t.co/wwDj1Bot5E
All mentions
Fecal Microbiota Transplantation for ALS Patients A Study Review
This video discusses the potential of fecal microbiota transplantation as a treatment for sporadic amyotrophic lateral sclerosis, based on a recent randomized, double-blind, placebo-controlled trial.
Fecal Transplant's Therapeutic Potential in ALS Patients
This randomized trial evaluated fecal transplant in ALS patients, showing significant improvements in constipation, depression, and anxiety, while providing valuable safety and feasibility data for this intervention.
Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis 孤発性筋萎縮性側索硬化症(ALS)患者における糞便微生物叢移植の効果 無作為化二重盲検プラセボ対照試験 https://t.co/lt2SjRIWQQ https://t.co/JrtdVs3C6l
Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. https://t.co/pQYbqxsTTz https://t.co/wWtV9esQMl
New trial highlights the gut #microbiome 's potential role in #ALS, specifically examining the effects of fecal #microbiota transplantation on sporadic ALS patients. https://t.co/8WrcAYO8OD https://t.co/gRmOEmvLrW
Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial - PubMed https://t.co/c1wNoMsdHw
散発性筋萎縮性側索硬化症患者に対する糞便微生物移植の効果:ランダム化二重盲検プラセボ対照試験 https://t.co/wwDj1Bot5E